Membranes prepared from stable transfected cells expressing the human gene encoding a functional 5-hydroxytryptaminelE (5HT1E) receptor were used to investigate high-affinity [3H]serotonin ([3H]5-HT) binding with scintillation proximity assay (SPA) technology. In this nonseparation format, membranes are captured by WGA-coated SPA fluoromicrospheres for detection of receptor-bound radioligand. Total binding observed was approximately 2000 cpm compared to a nonspecific signal of 100 cpm determined in the presence of 10,uM unlabeled 5-HT. Non-proximity effects (NPE) for the radiolabel and SPA beads averaged less than 100 cpm. Saturation binding analysis yielded an equilibrium dissociation constant (Kd) of 5.38 ± 0.43 nM and a maximum binding capacity (Bmax) of 6.42 + 0.15 pmol/mg protein. Competition with unlabeled serotonergic compounds demonstrated a specificity of the assay with rank potencies (5-HT > a-Me-5-HT > 2-Me-5-HT > 5-CT) similar to those observed using traditional fitration techniques. The variability of the assay and the stability of all reagents were investigated to validate the assay for extended use throughout a typical high throughput screen operation lasting several months.
Peroutka, S.J., Howell, T.A. (1994). The molecular evolution of G protein-coupled receptors: Focus on 5-hydroxytryptamine receptors. Neuropharmacology34:319.
3.
Jacobs, B.L., Azmitia, E.C. (1992). Structure and function of the brain serotonin system. Physiol. Rev.72:165.
4.
Martin, G.R., Humphrey, P.P.A. (1994). Receptors for 5-hydroxytryptamine: Current perspectives on classification and nomenclature. Neuropharmacology33:261.
5.
Baez, M., Kursar, J.D., Helton, L.A., Wainscott, D.B., Nelson, D.L.G. (1995). Molecular biology of serotonin receptors. Obes. Res.3:441S.
6.
Zgombick, J.M., Schechter, L.E., Macchi, M., Hartig, P.R., Branchek, T.A., Weinshank, R.L. (1992). Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor. Mol. Pharmacol.42:180.
7.
McAllister, G., Charlesworth, A., Snodin, C., Beer, M.S., Noble, A.J., Middlemiss, D.N., Iversen, L.L., Whiting, P. (1992). Molecular cloning of a serotonin receptor from human brain (5HTIE): A fifth 5HTlE-like subtype. Proc. Natl. Acad. Sci. U.S.A.89:5517.
8.
Levy, F.O., Gudermann, T., Birnbaumer, M., Kaumann, A.J., Birn-Baumer, L. (1992). Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclase. FEBS Lett.296:201.
9.
Leonhardt, S., Herrick-Davis, K., Titeler, M. (1989). Detection of a novel serotonin receptor subtype (5-HTlE) in human brain: Interaction with a GTP-binding protein. J. Neurochem. 53:465.
10.
Branchek, T., Adham, N., Macchi, M., Kao, H.-T., Hartig, P.R. (1990). [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H]ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. Mol. Pharmacol. 38:604.
11.
Adham, N., Romanienko, P., Hartig, P., Weinshank, R.L., Branchek, T. (1992). The rat 5-hydroxytryptaminelp receptor is the species homologue of the human 5-hydroxytryptamine1Dβ receptor. Mol. Pharmacol.41:1.
12.
Udenfriend, S., Diekmann-Gerber, L., Brink, L., Spector, S. (1985). Scintillation proximity radioimmunoassay utilizing 1251-labeled ligands. Proc. Natl. Acad. Sci. U.S.A.82:8672.
13.
Bosworth, N., Towers, P. (1989). Scintillation proximity assay. Nature341:167.
14.
Cook, N.D. (1996). Scintillation proximity assay: A versatile high-throughput screening technology. Drug Dis. Today1:287.
15.
Carrick, T.A., Bingham, B., Eppler, C.M., Baumbach, W.R., Zysk, J.R. (1995). A rapid and sensitive binding assay for growth hormone releasing factor. Endocrinology136:4701.
16.
Kodukula, K., Arcuri, M., Cutrone, J.Q., Hugill, R.M., Lowe, S.E., Pirnik, D.M., Shu, Y.Z. (1995). BMS-19548, a tetracyclic binding inhibitor of neuropeptide Y receptors, from Aspergillus niger WB2346. J. Antibiot (Tokyo)48:1055.
17.
Pernelle, C., Clerc, F.F., Dureuil, C., Bracco, L., Tocque, B. (1993). An efficient screening assay for the rapid and precise determination of affinities between leucine zipper domains. Biochemistry32:11682.
18.
Cheng, Y-C., Prusoff, W.H. (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (150) of an enzymatic reaction. Biochem. Pharmacol.22:3099.
Patel, S., Harris, A., O'Beirne, G., Cook, N.D., Taylor, C.W. (1996). Kinetic analysis of inositol trisphosphate binding to pure inositol trisphosphate receptors using scintillation proximity assay. Biochem. Biophys. Res. Comm.221:821.
21.
Udenfriend, S., Gerber, L., Nelson, N. (1987). Scintillation proximity assay: A sensitive and continous isotopic method for monitoring ligand/receptor and antigen/antibody interactions. Anal. Biochem.161:494.
